(S,Z)-N-(1-bromo-3-((1-hydroxy-3-phenylpropan-2-yl)amino)-3-oxo-1-phenylprop-1-en-2-yl)-4-chlorobenzamide

ID: ALA4761302

PubChem CID: 162660297

Max Phase: Preclinical

Molecular Formula: C25H22BrClN2O3

Molecular Weight: 513.82

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(N[C@H](CO)Cc1ccccc1)/C(NC(=O)c1ccc(Cl)cc1)=C(/Br)c1ccccc1

Standard InChI:  InChI=1S/C25H22BrClN2O3/c26-22(18-9-5-2-6-10-18)23(29-24(31)19-11-13-20(27)14-12-19)25(32)28-21(16-30)15-17-7-3-1-4-8-17/h1-14,21,30H,15-16H2,(H,28,32)(H,29,31)/b23-22-/t21-/m0/s1

Standard InChI Key:  QLXBIGXTTXOHTQ-MUBPVYAGSA-N

Molfile:  

 
     RDKit          2D

 32 34  0  0  0  0  0  0  0  0999 V2000
    1.4390   -1.3331    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4378   -2.1526    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1459   -2.5616    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8555   -2.1521    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8527   -1.3295    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1441   -0.9242    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1457   -3.3787    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4379   -3.7872    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
    2.8533   -3.7875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8531   -4.6047    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5611   -3.3791    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2687   -3.7879    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5613   -2.5619    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9765   -3.3794    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6841   -3.7882    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9767   -2.5622    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6845   -2.1538    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.6839   -4.6054    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5607   -5.0135    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5605   -5.8307    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2685   -4.6051    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8537   -6.2369    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8531   -7.0533    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5613   -7.4629    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2714   -7.0501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2685   -6.2350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9765   -5.0096    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9760   -5.8260    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6841   -6.2356    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3943   -5.8228    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3913   -5.0077    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5621   -8.2801    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  3  7  1  0
  7  8  1  0
  7  9  2  0
  9 10  1  0
  9 11  1  0
 11 12  1  0
 11 13  2  0
 14 12  1  6
 14 15  1  0
 14 16  1  0
 16 17  1  0
 15 18  1  0
 10 19  1  0
 19 20  1  0
 19 21  2  0
 20 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 20  1  0
 18 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 18  1  0
 24 32  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4761302

    ---

Associated Targets(Human)

HepG2 2.2.15 (869 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Hepatitis B virus (7925 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 513.82Molecular Weight (Monoisotopic): 512.0502AlogP: 4.55#Rotatable Bonds: 8
Polar Surface Area: 78.43Molecular Species: NEUTRALHBA: 3HBD: 3
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.86CX Basic pKa: CX LogP: 4.38CX LogD: 4.38
Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.39Np Likeness Score: -0.58

References

1. Gu X,Zhang Y,Zou Y,Li X,Guan M,Zhou Q,Qiu J.  (2021)  Synthesis and evaluation of new phenyl acrylamide derivatives as potent non-nucleoside anti-HBV agents.,  29  [PMID:33285406] [10.1016/j.bmc.2020.115892]

Source